This topic contains a solution. Click here to go to the answer

Author Question: When referring to the question of whether the experimental stimulus made some difference in the ... (Read 589 times)

drink

  • Hero Member
  • *****
  • Posts: 554
When referring to the question of whether the experimental stimulus made some difference in the specific instance under investigation, one is referring to
 a. external validity.
  b. internal validity.
  c. concomitant variation.
  d. cross sectional analysis.
  e. interaction errors.

Question 2

In regard to internal and external validity
 a. you can't have one without the other.
  b. procedures used to establish internal validity will also establish external validity.
  c. they are matters of degree rather than all or nothing propositions.
  d. neither is important in laboratory experiments.
  e. internal validity is a much more important issue in marketing than external validity.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
Marked as best answer by a Subject Expert

juicepod

  • Sr. Member
  • ****
  • Posts: 310
Answer to Question 1

b

Answer to Question 2

C




drink

  • Member
  • Posts: 554
Reply 2 on: Jun 29, 2018
Excellent


  • Member
  • Posts:
Reply 3 on: Yesterday
YES! Correct, THANKS for helping me on my review

 

Did you know?

A recent study has found that following a diet rich in berries may slow down the aging process of the brain. This diet apparently helps to keep dopamine levels much higher than are seen in normal individuals who do not eat berries as a regular part of their diet as they enter their later years.

Did you know?

Patients who cannot swallow may receive nutrition via a parenteral route—usually, a catheter is inserted through the chest into a large vein going into the heart.

Did you know?

When blood is exposed to air, it clots. Heparin allows the blood to come in direct contact with air without clotting.

Did you know?

Between 1999 and 2012, American adults with high total cholesterol decreased from 18.3% to 12.9%

Did you know?

As of mid-2016, 18.2 million people were receiving advanced retroviral therapy (ART) worldwide. This represents between 43–50% of the 34–39.8 million people living with HIV.

For a complete list of videos, visit our video library